20-62957499-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_022082.4(SLC17A9):c.316G>A(p.Val106Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,609,548 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00014 ( 1 hom. )
Consequence
SLC17A9
NM_022082.4 missense
NM_022082.4 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.298
Genes affected
SLC17A9 (HGNC:16192): (solute carrier family 17 member 9) This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006943941).
BP6
Variant 20-62957499-G-A is Benign according to our data. Variant chr20-62957499-G-A is described in ClinVar as [Benign]. Clinvar id is 3040082.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 187 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC17A9 | NM_022082.4 | c.316G>A | p.Val106Ile | missense_variant | 3/13 | ENST00000370351.9 | NP_071365.4 | |
SLC17A9 | NM_001302643.2 | c.298G>A | p.Val100Ile | missense_variant | 4/14 | NP_001289572.2 | ||
SLC17A9 | XM_011528978.3 | c.-45G>A | 5_prime_UTR_variant | 2/12 | XP_011527280.1 | |||
SLC17A9 | XR_936601.4 | n.438G>A | non_coding_transcript_exon_variant | 3/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC17A9 | ENST00000370351.9 | c.316G>A | p.Val106Ile | missense_variant | 3/13 | 1 | NM_022082.4 | ENSP00000359376 | P1 | |
SLC17A9 | ENST00000370349.7 | c.298G>A | p.Val100Ile | missense_variant | 4/14 | 1 | ENSP00000359374 | |||
SLC17A9 | ENST00000411611.1 | c.376G>A | p.Val126Ile | missense_variant | 3/3 | 2 | ENSP00000388215 | |||
SLC17A9 | ENST00000488738.5 | n.436G>A | non_coding_transcript_exon_variant | 3/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00123 AC: 187AN: 152142Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
187
AN:
152142
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000344 AC: 84AN: 244438Hom.: 1 AF XY: 0.000263 AC XY: 35AN XY: 133018
GnomAD3 exomes
AF:
AC:
84
AN:
244438
Hom.:
AF XY:
AC XY:
35
AN XY:
133018
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000135 AC: 197AN: 1457288Hom.: 1 Cov.: 34 AF XY: 0.000130 AC XY: 94AN XY: 725018
GnomAD4 exome
AF:
AC:
197
AN:
1457288
Hom.:
Cov.:
34
AF XY:
AC XY:
94
AN XY:
725018
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00123 AC: 187AN: 152260Hom.: 1 Cov.: 33 AF XY: 0.00126 AC XY: 94AN XY: 74442
GnomAD4 genome
AF:
AC:
187
AN:
152260
Hom.:
Cov.:
33
AF XY:
AC XY:
94
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
14
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
52
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC17A9-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at